| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5552394 | TEVA BRANDED PHARM | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
Jul, 2014
(9 years ago) | |
Loestrin 24 Fe is owned by Teva Branded Pharm.
Loestrin 24 Fe contains Ethinyl Estradiol; Norethindrone Acetate.
Loestrin 24 Fe has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Loestrin 24 Fe are:
- US5552394
Loestrin 24 Fe was authorised for market use on 17 February, 2006.
Loestrin 24 Fe is available in tablet;oral dosage forms.
Loestrin 24 Fe can be used as prevention of pregnancy.
The generics of Loestrin 24 Fe are possible to be released after 22 July, 2014.
Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ACETATE ingredient
Market Authorisation Date: 17 February, 2006
Treatment: Prevention of pregnancy
Dosage: TABLET;ORAL
How can I launch a generic of LOESTRIN 24 FE before it's drug patent expiration?
More Information on Dosage
LOESTRIN 24 FE family patents
